Chase Investment Counsel Corp Invests $1.85 Million in Bath & Body Works, Inc. $BBWI

Chase Investment Counsel Corp acquired a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 80,000 shares of the company’s stock, valued at approximately $1,850,000.

Other institutional investors also recently bought and sold shares of the company. Intech Investment Management LLC raised its position in shares of Bath & Body Works by 462.6% in the 4th quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock worth $2,184,000 after acquiring an additional 89,432 shares in the last quarter. Cibc World Market Inc. bought a new stake in Bath & Body Works during the fourth quarter valued at about $2,053,000. Bank of America Corp DE boosted its position in Bath & Body Works by 26.2% during the first quarter. Bank of America Corp DE now owns 2,050,414 shares of the company’s stock valued at $38,281,000 after purchasing an additional 425,248 shares in the last quarter. WINTON GROUP Ltd purchased a new position in Bath & Body Works in the fourth quarter valued at about $3,175,000. Finally, Vaughan Nelson Investment Management L.P. grew its stake in Bath & Body Works by 33.8% in the first quarter. Vaughan Nelson Investment Management L.P. now owns 2,852,040 shares of the company’s stock valued at $53,248,000 after purchasing an additional 719,795 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $19.40 on Monday. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $32.32. The company has a market cap of $3.91 billion, a PE ratio of 5.45, a P/E/G ratio of 1.92 and a beta of 1.38. The business has a 50-day simple moving average of $20.37 and a two-hundred day simple moving average of $20.16.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.29 by $0.03. The firm had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. Bath & Body Works’s revenue was down 3.2% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 2.63 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Investors of record on Friday, August 21st will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 4.1%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s dividend payout ratio is presently 22.47%.

Analyst Ratings Changes

Several analysts have commented on BBWI shares. Weiss Ratings raised shares of Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. The Goldman Sachs Group cut shares of Bath & Body Works from a “neutral” rating to a “sell” rating and lowered their price target for the company from $23.00 to $19.00 in a report on Wednesday, July 8th. TD Cowen lifted their price objective on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Telsey Advisory Group reduced their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a research note on Thursday, May 28th. Finally, Wells Fargo & Company increased their target price on shares of Bath & Body Works from $25.00 to $26.00 and gave the company an “overweight” rating in a research report on Tuesday, June 23rd. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Bath & Body Works presently has a consensus rating of “Hold” and a consensus target price of $21.93.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.